Hereditary Cystic Kidney Diseases Panel
Use
This test is for individuals with a clinical or suspected diagnosis of hereditary cystic kidney disease. It is also suitable for individuals with atypical ADPKD or ARPKD features that require differential diagnosis and for those with a family history of presumed cystic kidney disease without prior genetic testing.
Special Instructions
Testing options include Exome and Genome platforms, with the possibility of adding an exome-wide CNV analysis. STAT testing is available with a surcharge.
Limitations
The test has not been cleared or approved by the US Food and Drug Administration and should be interpreted in conjunction with clinical findings and family history. The performance characteristics of this test are subject to the specifics of the underlying NGS technology and sample quality.
New York Approved
Methodology
NGS (Targeted)
Biomarkers
Result Turnaround Time
2-3 weeks
Related Documents
For more information, please review the documents below
Specimen
Whole Blood
Volume
Not provided
Minimum Volume
Not provided